摘要:Introduction:? After partial-thickness skin graft (PTSG) harvesting, a dermal surface is exposed and an iatrogenic wound is created. Application of various agents has been studied for enhancement of healing process in PTSG donor area. The ideal agent should accelerate healing, provide comfort to the patient, not allow infection, and be easily applicable and cheap. Materials and Methods:? The Cochrane Central Register of Controlled Trials, PubMed, Scopus. and EMBASE databases were screened for words (“skin graft” + “donor”), by using time limits between 1989 and 2018. This study involved a total of 5 systematic reviews and 43 original articles which met the inclusion criteria. Articles were reviewed and parameters such as healing time, pain, infection rate, cosmetic result, and cost were extracted. Results:? Systematic reviews favor moist dressing materials over dry ones considering healing time and patient comfort. Hydrocolloids provide rapid wound healing, and dressing changes do not cause any disruption to the newly regenerated epithelium. Alginates seem to have a longer healing time than hydrocolloid materials. Polyurethane films are characterized by rapid epithelialization and painless monitoring as well as low costs. The epithelialization time of MEBO?, a cosmeceutical product, is reported to be faster than polyurethane films. Local and systemic drug applications warrant further research before routine clinical usage. Conclusion:? Dressing materials are the most commonly used and appropriate group according to the studies performed to date. It is seen that moist dressing materials are more favorable. Although there is not a subgroup with a clear superiority, it can be seen that the hydrofiber and polyurethane film groups are one step ahead in terms of ease of use, patient comfort, epithelialization speed, and scar quality. Polyurethane films have a cost advantage to the hydrofiber group.
期刊论文
Medical and Cosmeceutical Applications for Enhancement of Partial-Thickness Skin Graft Donor-Site Healing
期刊论文
MEBO联合CO<sub>2</sub>激光治疗腋臭50例临床观察
摘要:本文在腋臭CO2激光术后应用湿润烧伤膏治疗50例患者,并与单纯CO2激光治疗进行对照,结果,两周后联合组治愈率95%,对照组治愈率85%,平均痊愈时间分别为12±2天及13±2天,两组疗效比较有显著性差异(p<0.05),且疗程明显缩短(P<0.01),证实,湿润烧伤膏有明显促进CO2激光术后创面愈合作用,且能有效地防治CO2激光术后反应及瘢痕形成。
期刊论文
MEBO用于CO<sub>2</sub>激光治疗肛肠病术后临床体会(附6810例报告)
摘要:本文采用完全随机平行对照的设计方法对MEBO、九华膏、凡士林进行CO2激光治疗肛肠病术后创面换药的临床试验,经对照观察,结果显示MEBO具有抗菌。消炎、止痛、消肿、生肌长皮及减少术后赢痕组织生成等作用,三组依序递减(P<0.05或0.01)MEBO用于肛肠病术后换药能明显缩短术后痊愈时间,减轻术后并发症发生。
期刊论文
MEBO治疗皮肤毛细血管瘤CO<sub>2</sub>激光术后创面的疗效观察
摘要:目的:观察MEBO治疗皮肤毛细血管瘤CO2激光术后创面的疗效。方法:86例随机分为两组,MEBO组在CO2激光术后,创面采用湿润烧伤膏(MEBO)治疗,传统组采用外科换药法治疗(外用0.5%碘伏),观察它们的创面愈合时间、创面恢复后的外观状态等。结果:外用MEBO组创面平均愈合时间10.5天±1.6天,外观理想;对照组创面平均愈合时间17.0天±2.1天,15例17处创面出现扁平瘢痕。结论:MEBO治疗皮肤毛细血管瘤CO2激光术后的创面疗效显著。